Top Midday Stories: Merck to Acquire Cidara Therapeutics for $9.2 Billion; Walmart Names John Furner as CEO

MT Newswires Live
11/15

The S&P 500 and Nasdaq Composite rose in midday trading, erasing earlier declines, and the Dow Jones Industrial Average eased.

In company news, Merck (MRK) agreed to acquire Cidara Therapeutics (CDTX) for $9.2 billion, or $221.50 a share in cash. The transaction is expected to close in Q1 2026. Merck shares rose 1.5% at midday, and Cidara more than doubled.

Walmart (WMT) said its board elected John Furner as president and chief executive officer, effective Feb. 1, 2026. Furner will succeed Doug McMillon, who will retire on Jan. 31 and remain on the board until the next annual shareholders meeting. Furner has served as president and CEO of Walmart US since 2019. Walmart shares fell 1.4%.

Applied Materials (AMAT) reported fiscal Q4 adjusted earnings late Thursday of $2.17 per diluted share, down from $2.32 a year earlier. Analysts polled by FactSet expected $2.11. Revenue in the three months ended Oct. 26 fell to $6.8 billion from $7.05 billion. Analysts projected $6.68 billion. The company expects Q1 adjusted EPS of $2.18 on revenue of $6.85 billion. Analysts forecast EPS of $2.14 on revenue of $6.79 billion. Applied Materials shares edged up 0.1% at midday.

StubHub Holdings (STUB) reported a Q3 loss late Thursday of $4.27 per diluted share, widening from the loss of $0.15 a year earlier. Analysts polled by FactSet expected a loss of $2.87. Revenue rose to $468.1 million from $433.8 million. Analysts projected $451.8 million. StubHub shares tumbled 20% at midday after the company withheld guidance.

Price: 94.29, Change: +1.35, Percent Change: +1.46

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10